-+ 0.00%
-+ 0.00%
-+ 0.00%

Fuan Pharmaceutical announced that the company's wholly-owned subsidiaries Tianheng Pharmaceutical, Zhichu Pharmaceutical, and Renmin Pharmaceutical participated in the 12th batch of national centralized drug procurement tenders on July 31, 2026. The three drugs nicardipine hydrochloride injection, injectable techolanin, and injectable isaconazole sulfate are to be selected. The procurement period starts from the date of implementation of the selection results to December 31, 2029. None of the products to be selected above will have production and sales revenue in 2025.

Zhitongcaijing·08/03/2026 07:57:04
Listen to the news
Fuan Pharmaceutical announced that the company's wholly-owned subsidiaries Tianheng Pharmaceutical, Zhichu Pharmaceutical, and Renmin Pharmaceutical participated in the 12th batch of national centralized drug procurement tenders on July 31, 2026. The three drugs nicardipine hydrochloride injection, injectable techolanin, and injectable isaconazole sulfate are to be selected. The procurement period starts from the date of implementation of the selection results to December 31, 2029. None of the products to be selected above will have production and sales revenue in 2025.